|
1
|
Muz B, de la Puente P, Azab F and Azab AK:
The role of hypoxia in cancer progression, angiogenesis,
metastasis, and resistance to therapy. Hypoxia (Auckl). 3:83–92.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farris AB, Adams CD, Brousaides N, Della
Pelle PA, Collins AB, Moradi E, Smith RN, Grimm PC and Colvin RB:
Morphometric and visual evaluation of fibrosis in renal biopsies. J
Am Soc Nephrol. 22:176–186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baeriswyl V and Christofori G: The
angiogenic switch in carcinogenesis. Semin Cancer Biol. 19:329–337.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Q, Jin M, Yang F, Zhu J, Xiao Q and
Zhang L: Matrix metalloproteinases: Inflammatory regulators of cell
behaviors in vascular formation and remodeling. Mediators Inflamm.
2013:9283152013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loayza-Puch F, Yoshida Y, Matsuzaki T,
Takahashi C, Kitayama H and Noda M: Hypoxia and RAS-signaling
pathways converge on, and cooperatively downregulate, the RECK
tumor-suppressor protein through microRNAs. Oncogene. 29:2638–2648.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Basilico N, Magnetto C, D'Alessandro S,
Panariti A, Rivolta I, Genova T, Khadjavi A, Gulino GR, Argenziano
M, Soster M, et al: Dextran-shelled oxygen-loaded nanodroplets
reestablish a normoxia-like pro-angiogenic phenotype and behavior
in hypoxic human dermal microvascular endothelium. Toxicol Appl
Pharmacol. 288:330–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ben-Yosef Y, Lahat N, Shapiro S, Bitterman
H and Miller A: Regulation of endothelial matrix
metalloproteinase-2 by hypoxia/reoxygenation. Circ Res. 90:784–791.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galm O, Suzuki H, Akiyama Y, Esteller M,
Brock MV, Osieka R, Baylin SB and Herman JG: Inactivation of the
tissue inhibitor of metalloproteinases-2 gene by promoter
hypermethylation in lymphoid malignancies. Oncogene. 24:4799–4805.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lahat N, Bitterman H, Engelmayer-Goren M,
Rosenzweig D, Weiss-Cerem L and Rahat MA: Reduced TIMP-2 in hypoxia
enhances angiogenesis. Am J Physiol Cell Physiol. 300:C557–C566.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin H, Pan JC, Zhang FM, Huang B, Chen X,
Zhuang JT, Wang H, Mo CQ, Wang DH and Qiu SP: Matrix
metalloproteinase-9 is required for vasculogenic mimicry by clear
cell renal carcinoma cells. Urol Oncol. 33(168): e9–e16. 2015.
|
|
11
|
Hamano Y, Zeisberg M, Sugimoto H, Lively
JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A and Kalluri R:
Physiological levels of tumstatin, a fragment of collagen IV alpha3
chain, are generated by MMP-9 proteolysis and suppress angiogenesis
via alphaV beta3 integrin. Cancer Cell. 3:589–601. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SY, Hörbelt M, Mang HE, Knipe NL,
Bacallao RL, Sado Y and Sutton TA: MMP-9 gene deletion mitigates
microvascular loss in a model of ischemic acute kidney injury. Am J
Physiol Renal Physiol. 301:F101–F109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Galvez BG, Matías-Román S, Albar JP,
Sánchez-Madrid F and Arroyo AG: Membrane type 1-matrix
metalloproteinase is activated during migration of human
endothelial cells and modulates endothelial motility and matrix
remodeling. J Biol Chem. 276:37491–37500. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kachgal S, Carrion B, Janson IA and Putnam
AJ: Bone marrow stromal cells stimulate an angiogenic program that
requires endothelial MT1-MMP. J Cell Physiol. 227:3546–3555. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ando K, Ishibashi T, Ohkawara H, Inoue N,
Sugimoto K, Uekita H, Hu C, Okamoto Y, Takuwa Y and Takeishi Y:
Crucial role of membrane type 1 matrix metalloproteinase (MT1-MMP)
in RhoA/Rac1-dependent signaling pathways in thrombin-stimulated
endothelial cells. J Atheroscler Thromb. 18:762–773. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noda K, Ishida S, Shinoda H, Koto T, Aoki
T, Tsubota K, Oguchi Y, Okada Y and Ikeda E: Hypoxia induces the
expression of membrane-type 1 matrix metalloproteinase in retinal
glial cells. Invest Ophthalmol Vis Sci. 46:3817–3824. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miyoshi A, Kitajima Y, Ide T, Ohtaka K,
Nagasawa H, Uto Y, Hori H and Miyazaki K: Hypoxia accelerates
cancer invasion of hepatoma cells by upregulating MMP expression in
an HIF-1alpha-independent manner. Int J Oncol. 29:1533–1539.
2006.PubMed/NCBI
|
|
18
|
Li J, Zucker S, Pulkoski-Gross A, Kuscu C,
Karaayvaz M, Ju J, Yao H, Song E and Cao J: Conversion of
stationary to invasive tumor initiating cells (TICs): Role of
hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP)
trafficking. PLoS One. 7:e384032012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu J, Ni S, Cao Y, Zhang T, Wu T, Yin X,
Lang Y and Lu H: The Angiogenic Effect of microRNA-21 Targeting
TIMP3 through the Regulation of MMP2 and MMP9. PLoS One.
11:e01495372016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Liu L, Liu J, Cheng Z, Wang Z,
Shi C, Ding F, Chen S and Chen P: Endothelial cells co-cultured
with renal carcinoma cells significantly reduce RECK expression
under chemical hypoxia. Cell Biol Int. 41:922–927. 2017. View Article : Google Scholar : PubMed/NCBI
|
